z-logo
Premium
Efficacy of subcutaneous preemptive rituximab in immune‐mediated thrombotic thrombocytopenic purpura: Experience from the first 12 cases
Author(s) -
Delrue Maxime,
Baylatry Minh Tam,
Joly AnneChristine,
Corre Elise,
Marjanovic Zora,
ElKhouryHanoujoud,
Féger Frédéric,
Suner Ludovic,
Veyradier Agnès,
Stépanian Alain,
Coppo Paul
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26022
Subject(s) - rituximab , adamts13 , medicine , thrombotic thrombocytopenic purpura , von willebrand factor , cd20 , gastroenterology , immunology , antibody , platelet

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom